Reproductive Health Innovation Summit 2022

Reproductive Health Innovation Summit

Connecting industry leaders to spark innovation, investment, access, and solutions across the reproductive health spectrum

Download Agenda
Boston, USA
15-16 February, 2022

“As always, I am excited to engage with this community of inspiring women’s health innovators and learn about the new solutions bridging the healthcare gap for women globally.”

Erica Kantor, Head of Women’s Health, Sagentia Innovation

WHI SERIES ADVISORY BOARD 2022

WHY ATTEND? 

Reproductive health is set to hold a leading market share of the women’s health industry, with an estimated global worth of $171 billion by 2027. 

Start-ups, Femtech, and Technology Innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.

The Reproductive Health Innovation Summit (February 15-16) is the destination for uncovering what is next in fertility, contraception and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices & solutions and new care delivery models.

Join us to:

  • Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.

  • Dive into 1 of our 3 leading innovation tracks: Contraception, Fertility or Maternal Health to discover the latest research, innovations and sector-specific challenges and opportunities.

  • Network with the leaders and changemakers with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.

Add to the innovation and attend alongside our leading network of biotechs, start-ups, Femtech, insurers, CROs, investors, medical device companies, researchers, pharmaceuticals, HCPs and advocacy groups to drive innovation at the convergence of healthcare and technology.

2022 Innovation Spotlight

Showcasing the most innovative and disruptive companies in reproductive health.

18 opportunities at this years’ summit!

9 reproductive health focused start-ups, selected by our prestigious Selection Committee, will take to the stage in quick-fire round of presentations, demonstrating their vision of the reproductive health industry of the future, and what role their technology, product, or service plays in that.

3 finalists will be selected from each of the 3 innovation categories: contraception, fertility and maternal health, to give a 3-minute pitch of their company in front of 100s of industry leaders and strategic, corporate partners.

The 3 runners-up in each category will have the opportunity to enter a ‘lightening round’ of 1- minute pitches on-stage.

Applications are stage agnostic, and we encourage anyone to apply with a vision of a better reproductive health industry of the future.

Application deadline: 9th December 2021

Receive $100 off your ticket by applying! APPLY TODAY

All details shared with the committee are strictly confidential. The more detailed application form, the more information the selection committee can use to make their decision. However, if you do not wish to fill in a question, please feel free to leave it blank. 

APPLY HERE

2022’S PRESTIGIOUS SELECTION COMMITTEE OF INVESTORS

FREE TO ATTEND WEBINAR

2022 Partners

Platinum Partner

Gold Partner

Media Partners

2022 Speakers

 

Elena Gambon

VP Business Development
First Stop Health

Elena Gambon

VP Business Development
First Stop Health

Elena Gambon

VP Business Development
First Stop Health
 

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures
 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner

Chief Medical Officer
Obseva
 

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson
 

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers
 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.

 

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60
 

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility
 

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles
 

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG
 

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers
 

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics
 

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health
 

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association
 

Sateria Venable

Founder
The Fibroid Foundation

Sateria Venable is the Founder & CEO of The Fibroid Foundation (www.fibroidfoundation.org), a global, patient-founded advocacy organization.
The Fibroid Foundation develops programming to support its community of over 25,000 women. Sateria began her advocacy efforts in 2007. Since that time, the organization has developed a substantial network within the medical community.

Sateria Venable

Founder
The Fibroid Foundation

Sateria Venable

Founder
The Fibroid Foundation

Sateria Venable is the Founder & CEO of The Fibroid Foundation (www.fibroidfoundation.org), a global, patient-founded advocacy organization.
The Fibroid Foundation develops programming to support its community of over 25,000 women. Sateria began her advocacy efforts in 2007. Since that time, the organization has developed a substantial network within the medical community.


Venable, who holds a Bachelor of Architecture from Carnegie Mellon University, has co-authored several scientific papers on fibroid research. She is the inventor of an undergarment inspired by her journey, that she hopes will transform intimate apparel for all women. A sought-after speaker, she has been featured in print and radio media, and has presented at gynecologic conferences worldwide.

 

Amanda Gorman

Founder & Clinical Director
Nest Collaborative

Amanda Gorman

Founder & Clinical Director
Nest Collaborative

Amanda Gorman

Founder & Clinical Director
Nest Collaborative
 

Sara Naseri

CEO
QVIN

Sara Naseri

CEO
QVIN

Sara Naseri

CEO
QVIN
 

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan
 

Sarah Chamberlain

Partner
Boston Consulting Group

Sarah Chamberlain

Partner
Boston Consulting Group

Sarah Chamberlain

Partner
Boston Consulting Group
 

Katie Schubert

MPP, President & CEO
Society of Women's Health Research

Katie Schubert

MPP, President & CEO
Society of Women's Health Research

Katie Schubert

MPP, President & CEO
Society of Women's Health Research
 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative
 

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical
 

Priyanka Jain

Co-Founder & CEO
Evvy

Priyanka Jain

Co-Founder & CEO
Evvy

Priyanka Jain

Co-Founder & CEO
Evvy
 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Audrey Anderson Duckett

Chief Operating Officer
Be Girl

Audrey Anderson Duckett

Chief Operating Officer
Be Girl

Audrey Anderson Duckett

Chief Operating Officer
Be Girl
 

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center
 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria
 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Emily Zhen

Health Venture Capital Investor
New Enterprise Associates

Emily Zhen

Health Venture Capital Investor
New Enterprise Associates

Emily Zhen

Health Venture Capital Investor
New Enterprise Associates
 

Deena Shakir

Partner
LUX Capital

Deena Shakir

Partner
LUX Capital

Deena Shakir

Partner
LUX Capital
 

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures
 

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice
 

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio
 

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen
 

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions
 

Rachel Blank

Founder & CEO
Allara

Rachel Blank

Founder & CEO
Allara

Rachel Blank

Founder & CEO
Allara
 

Katie Williams

MPH, Technical Officer
FHI360

Katie Williams

MPH, Technical Officer
FHI360

Katie Williams

MPH, Technical Officer
FHI360
 

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Download 2022 agenda

Be the first to view our 2021 Reproductive Health Innovation Summit agenda!

Sessions include:

  • Investment, Innovation & Reproductive Health: Where does Technology Stand today?
  • The IVF Clinic Market of the Future: Exploring the Impact of PE investment
  • Male Reproductive Health & The Impact on Women's Health
  • Sex & Gender in Medicine, Research & Practice

Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!

Download the Reproductive Health Innovation Summit Agenda

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICES INCREASE IN

Saturday, December 4, 2021 to Friday, January 14, 2022
Emerging / Start-ups
$899
Early Bird
Saturday, December 4, 2021 to Friday, January 14, 2022
Industry
$1,599
Early Bird
Saturday, December 4, 2021 to Friday, January 14, 2022
Service Providers
$1,999
Early Bird
Preparing registration...

RESOURCES

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us